Note the descending aorta: predictors of postoperative major adverse aortic event in pure acute type A intramural hematoma

BackgroundIntramural hematomas (IMHs) may originate from small intimal tears. Although most surgeries for acute type A IMH are conventionally performed solely at the proximal aorta, regardless of the primary intimal tear site, the remnant aortic remodeling stays important during the follow-up period after surgery.MethodsForty-seven patients with “pure” acute type A IMHs who underwent surgery from January 2008 to December 2019 were retrospectively analyzed. Acute type A IMH in the entire region without penetrating aortic ulcer (PAU) and aortic dissection (AD), which upon initial computed tomography (CT), can be considered as an intimal tear site, was defined as “pure” type. The maximal diameter of the aorta, maximal thickness of the IMH, and hematoma thickness ratio (HTR) of the ascending and descending aortae were measured from the preoperative computed tomographic scan. The hematoma thickness index was defined as the HTR of the descending aorta divided by that of the ascending aorta. Major adverse aortic events (MAAEs) were defined as AD, rupture, or newly developed PAU and aortic death. Predictors for postoperative MAAEs were analyzed using preoperative computed tomographic findings.ResultsThe measurements of the descending aorta were larger and those of the ascending aorta were smaller in the MAAEs group, than in the corresponding other. The hematoma thickness index was significantly higher in the group with MAAEs, than in the group without; this variable was an independent predictor of MAAEs. During surgery, intimal tears were found in 16/47 (34%) patients. The hematoma thickness index was significantly smaller in the group with intimal tears than in the group without the tears. The aortic measurement appears to reflect the tear site.ConclusionsHematoma thickness index was an independent predictor of MAAE after acute type A IMH surgery. Long-term periodical follow-up with early reintervention may, therefore, be necessary to improve outcome in these patients. As the optimal treatment method is still controversial, inferring the location of the primary tear through the hematoma thickness index can be helpful in determining the treatment method.     

Different clinical features of aortic intramural hematoma versus dissection involving the descending thoracic aorta

OBJECTIVE: The objective of this study is to test the hypothesis that the absence of flow communication in aortic intramural hematoma (IMH) involving the descending aorta may have a different clinical course compared with aortic dissection (AD). METHODS: We prospectively evaluated clinical and echocardiographic data in AD (76 patients) and IMH (27 patients) of the descending thoracic aorta. RESULTS: Patients did not differ with regard to age, gender, or clinical presentation. IMH and AD had the same predictors of complications at follow-up: aortic diameter (>5 cm) at diagnosis and persistent back pain. Surgical treatment was more frequently selected in AD (39% vs. 22%, P < 0.01) and AD patients who underwent surgical treatment had higher mortality than those with IMH (36% vs. 17%, P < 0.01). There was no difference in mortality with medical treatment (14% in AD vs. 19% in IMH, P = 0.7). During follow-up, of 23 patients with IMH, 11 (47%) showed complete resolution or regression, 6 (26%) increased the diameter of the descending aorta, and typical AD developed in 3 patients (13%). No changes occurred in 14% of the group. Three-year survival rate did not show significant differences between both groups (82 +/- 6% in IMH vs. 75 +/- 7% in AD, P = 0.37). CONCLUSION: IMH of the descending thoracic aorta has a relatively frequent rate of complications at follow-up, including dissection and aneurysm formation. Medical treatment with very frequent imaging and timed elective surgery in cases with complications allows a better patient management.     

Ulcer-like projections into the dilated false lumen after stent-graft placement for aortic dissection: A case report

Rationale:Acute type A aortic dissection and chronic type B aortic dissection (TBAD) occurs simultaneously in rare cases. Although the development of ulcer-like projection (ULP) is associated with an increase in adverse aorta-related events, the false-lumen enlargement caused by the ULP progression is uncommon.Patient concerns:A 72-year-old female with chronic TBAD was admitted to our unit with back and chest pain. Computed tomography revealed acute type A aortic dissection and a hematoma caused by rupturing of the descending aorta due to chronic TBAD. After endovascular intervention, the false lumen thrombosed and shrunk.Diagnosis:After 9 months, a developing ULP, which projected into a dilating false lumen, was found. An impending ruptured descending aortic aneurysm was confirmed.Interventions:Emergency Total arch replacement and thoracic endovascular aortic repair (TEVAR) was performed.Outcomes:The procedure was successful. One year later, regular follow-up showed that the false lumen had completely shrunk.Lessons:ULP can arise and cause progressive dilation of false lumen after TEVAR. Careful and regular computed tomography examinations are required for early diagnosis of false lumen becoming thrombosed after TEVAR. Close follow-up and timely intervention, including TEVAR, should be considered in cases of aortic enlargement due to a newly developed ULP.     

Difficulty Diagnosing Retrograde Type A Aortic Dissection with Intramural Hematoma and Risk of Re-dissection and Rupture: A Report of Two Cases

Acute type A aortic dissection is a potentially fatal disease, and emergency surgery should be considered when it is diagnosed. We herein report two cases of retrograde type A aortic dissection with intramural hematoma, followed by re-dissection, rupture, and cardiac tamponade. The diagnoses in these cases had to be made carefully, as the false lumen of the ascending aorta was sometimes unclear on contrast-enhanced computed tomography.     

The usefulness of contrast-enhanced echocardiography in the diagnosis and management of intramural hematoma and aortic dissection: A case report

Contrast-enhanced transthoracic echocardiography (cTTE) plays an important role in the diagnosis of intramural hematoma (IMH) and aortic dissection (AD), and is also necessary for the adequate management from the assessment of findings. We hereby present an interesting case in which cTTE provides additional value over contrast-enhanced computed tomography (CT) in the diagnosis and the morphological characterization of IMH and AD. A 58-year-old man presented to the emergency department with intermittent chest pain. After emergency consultation, an enhanced CT scan showed an acute aortic intramural hematoma involving aortic arch and descending aorta. Nevertheless, the entry tear and false lumen flow direction were identified by cTTE, which suggested an acute type B AD.     

Open Repair of Acute Type A Intramural Hematoma in 3 Patients

Acute aortic syndrome encompasses classic aortic dissection and less common aortic phenomena, including intramural hematoma (IMH), a hemorrhage within the aortic media that occurs without a discrete intimal tear. We reviewed our experience with treating acute type A IMH to better understand this acute aortic syndrome. A review of our clinical database identified 1,902 proximal aortic repairs that were performed from January 2006 through December 2018; of these, 266 were for acute aortic syndrome, including 3 (1.1%) for acute type A IMH. Operative technique varied considerably. All IMH repairs involved hemiarch or total arch replacement. In all 3 patients, the IMH extended distally into the descending thoracic aorta. There were no operative deaths or major adverse events (stroke, paraplegia, paraparesis, or renal failure necessitating dialysis) that persisted to hospital discharge. Length of hospitalization ranged from 5 to 20 days. All 3 patients were alive at follow-up (range, 2–6 yr) and needed no aortic reintervention after their index or staged repairs. In our experience, repair of acute type A IMH was infrequent and could be either simple or complex. Despite our limited experience with this disease, we found that it can be repaired successfully in urgent and emergency cases. Following treatment guidelines for aortic dissection appears to be a reasonable strategy for treating IMH.     

B型主动脉壁间血肿治疗策略的选择

目的:探讨Standford B型主动脉壁间血肿的治疗策略的选择。方法: 总结我院2年期间通过内科药物和腔内修复手术治疗的Standford B型主动脉壁间血肿患者16例,根据患者治疗结果进行评价主动脉壁间血肿治疗策略的选择。结果: 16例患者中,药物治疗的患者6例,腔内修复治疗的患者10例（其中4例是由于药物治疗后症状持续加重转为腔内修复手术治疗的）。腔内治疗患者均存活,药物治疗组中死亡2例,均为出现急性主动脉夹层引起死亡。结论: 腔内修复治疗对于Standford B主动脉壁间血肿是安全可行治疗选择。     

TEVAR for non‐aneurysmal thoracic aortic pathology

Objective : Management of penetrating atherosclerotic ulcers (PAU), intramural hematomas (IMH), and acute aortic dissections (AD) of the thoracic aorta remain controversial in the endovascular era. Methods : Between 2001 and 2007, patients with PAU (13 patients), and/or IMH (7 patients) were treated with thoracic endografts (TEVAR) in the endovascular suite under general anesthesia. Indications for intervention were intractable chest pain, expanding hematoma or contained rupture, or distal malperfusion. End‐points were early morbidity and mortality, incidence of endoleak, device‐related complications, and secondary interventions. Results : Of the 20 patients with a median age of 67 (25–83), 13 (65%) were men, 2 (10%) had contained aortic rupture, and 10 were symptomatic. One patient had carotid‐subclavian bypass debranching before endograft implantation. Ten patients had cerebrospinal fluid drainage. Mean length of aorta treated was 122.1 mm (range 36–300). All endografts were technically successful. Average blood loss was 50 mL. Thirty‐day mortality was 0%. Symptoms resolved in all patients; there were no neurologic complications. Average length of stay was 5 days. Mean follow‐up was 2.0 years (range 0.1–5.8). All patients remained asymptomatic. Three had early (<180 days) endoleaks: Two type II and 1 type I treated successfully with an additional cuff, which was the only patient requiring reintervention. Two patients had late (>180 days) endoleaks (type 2) observed with no aortic expansion. Two deaths at 5.4 and 5.8 years were due to severe aortic valve stenosis and metastatic lung cancer. Conclusion : TEVAR is a feasible option for repair of non‐aneurysmal thoracic aortic pathology with resolution of symptoms, no mortality, and no neurologic complications. © 2009 Wiley‐Liss, Inc.     

急性期Standford B型主动脉夹层腔内修复术后早、中期随访结果

目的 评价急性期StanfordB型胸主动脉夹层(TAD)腔内修复术后早、中期手术效果.方法 2009年11月至2012年6月完成80例急性期Stanford B型胸主动脉夹层腔内修复术,手术在发病72 h内完成.手术前行胸腹主动脉夹层强化CT检查,在DSA手术室全麻下切开股动脉进行支架置入术,出院前进行CTA检查,手术后半年至一年内复查CTA.结果 14例患者手术后失去随访.5例术后造影提示有Ⅰ型内漏,4例1年内复查消失或造影剂溢出量明显减少,1例手术后仍有明显Ⅰ型内漏,1年后接受再次支架手术成功.其余支架安装后造影显示破口封闭,无内漏.住院期间死亡2例,1例为高龄患者降主动脉破裂,1例为夹层逆行撕裂至升主动脉后破裂.住院期间发生严重低氧血症8例,急性肾功能不全6例,均经治疗后恢复.结论 急性期Stanford B型胸主动脉夹层进行腔内修复术,术后早期并发症发生率高,中期效果理想.     

Stanford B型主动脉壁内血肿患者发生主动脉相关不良事件的临床特征及影像学分析

目的 评价Stanford B型壁内血肿（IMH）患者发生主动脉相关不良事件的临床特点和预后因素。 方法 回顾性分析2013年4月至2021年3月就诊于北部战区总医院的IMH患者共579例,根据纳入标准和排除标准,最终有372例IMH患者入选。根据是否发生主动脉相关不良事件分为事件组（n = 81）和对照组(n = 291),观察两组患者的临床特征及确诊时的首次影像学特征。 结果 两组患者性别、吸烟史、高血压病史、糖尿病史、脑血管病史等差异均无统计学意义,事件组患者年龄显著小于对照组[（59 ± 11）岁VS（65 ± 10）岁,P<0.01],对比两组患者临床特征和首次确诊的主动脉增强CT（CTA）参数,行logistic回归分析提示,年龄（OR = 0.943, 95%CI:0.913-0.974;P<0.01）,CTA中测量的降主动脉最大直径(OR = 1.325, 95%CI:1.231-1.425;P<0.01),壁内血肿并发溃疡样突起（OR = 3.975, 95%CI:1.744-9.060;P<0.01）是预测IMH患者发生主动脉相关不良事件的独立危险因素。 结论 单中心资料表明,对于Stanford B型IMH患者,首次确诊时年龄小,首次CTA中的降主动脉最大直径增大、并发溃疡样凸起可以预测主动脉相关不良事件发生。     

Clinical Implications of Focal Intimal Disruption in Patients With Type B Intramural Hematoma

Background

Focal intimal disruption (FID) has been described in >20% of type B intramural hematomas (IMH), with unclear prognosis and management.

胸主动脉腔内修复术治疗Stanford B型主动脉夹层

目的 总结胸主动脉腔内修复术（thoracic endovascular aortic repair,TEVAR）治疗Stanford B型主动脉夹层的临床经验.方法 回顾性分析134例Stanford B型主动脉夹层患者的临床资料,分析并发症发生的原因及随访近、远期效果.结果 术前死亡4例,未手术1例,施行TEVAR 129例,手术操作均成功,部分封堵左锁骨下动脉27例（20.9％）,完全封闭左锁骨下动脉12例（9.3％）;Ⅰ型内漏13例（10.1％）,夹层逆剥为Stanford A型1例,低氧血症23例（17.8％）,肾功能衰竭需血液滤过9例（7.1％）,术后精神症状37例（28.7％）,脑梗死3例.随访2个月～5年,随访110例,随访率85.7％,1例术后1年和1.5年出现支架远端夹层,两次手术植入覆膜支架,部分封闭了腹腔干动脉,1例术后2个月时因肠梗阻在外院行手术治疗,1例术后4年时支架远端发生夹层破裂死亡,1例术后3个月突然死亡.Ⅰ型内漏消失11例,持续存在2例.结论 急诊TEVAR治疗Stanford B型主动脉夹层安全、可靠,近期效果良好,加强并发症的防治,可进一步改善临床效果.     

Intramural hematoma of the arch and ascending aorta owing to acute aortic syndrome of the descending aorta: to stent or not to stent?

Purpose: To report thoracic stent-graft repair in patients with acute aortic syndromes, an intramural hematoma (IMH), and intractable pain despite maximum medical therapy. Case Reports: Since January 2002, 4 patients [2 men (40 and 53 years old) and 2 woman (62 and 83 years old)] with type B aortic dissection have presented with an IMH >3 mm in the aortic arch. The patients were treated with a "freeflo" Valiant thoracic stent-graft, which was deployed under "zero aortic pressure" using either adenosine arrest or rapid ventricular pacing. To enhance false lumen thrombosis, a distal extension was inserted when a significant re-entry was observed in the mid third of the descending thoracic. The procedures were successful; over a follow-up ranging to 17 months, the patients have been asymptomatic, with resolution of all the IMHs. Conclusion: Thoracic stent-graft treatment of acute aortic syndromes of the descending aorta complicated by arch IMH is feasible. Success of the procedure may rely on optimal stent-graft selection with minimal graft oversizing, deployment under "zero aortic pressure" using rapid ventricular pacing, and more liberal revascularization of the left subclavian artery.     

Endovascular treatment of thoracic aortic disease: mid-term follow-up.

OBJECTIVE: The aim of this study was to evaluate the mid-term follow-up in a cohort of patients with acute or chronic descending aortic disease treated by stent-graft repair. BACKGROUND: Since 1999, endovascular stent-graft placement has been reported as an alternative treatment to surgical approach for a variety of thoracic aortic diseases; however, results beyond initial short-term follow-up are not widely available for the broad range of applications. METHODS: From March 2001, 43 consecutive patients with traumatic aortic transection (group A = 16) and complicated type B aortic dissection or aneurysm (group B = 27) underwent stent-graft implantation. All patients underwent computed tomography (CT) scan as preoperative assessment and in 26 a transesophageal echo (TEE) exam was performed. RESULTS: Technically successful stent-graft deployment was achieved in all patients. No patient required surgical conversion and no cases of paraplegia occurred. The overall in-hospital mortality was 9.3%. A residual endoleak (type II) was detected in one group B patient who was managed conservatively. The mean follow-up was 29 +/- 8 months (range 10-48 months). No patient died during late follow-up after hospital discharge. At 12 months, one patient (2.5%) who had stent graft repair of an aortic dissection developed an asymptomatic type I endoleak. Three asymptomatic patients with chronic dissection had a persistent retrograde perfusion of the thoracic false lumen via a distal tear(s) in the dissection septum. CONCLUSION: Our results of stent-graft treatment of complicated and uncomplicated diseases of the descending aorta confirms that this alternative to open repair is a safe, less invasive, and relatively low risk approach. Medium-term follow-up results suggest that it is effective and durable therapy with low associated mortality and morbidity rates.     

Hématome intramural de l’aorte thoracique : traitement médical ou chirurgie ?

Intramural hematoma (IMH) of the aorta is an uncommon entity. This disease shares many characteristics with acute aortic dissection. Treatment of IMH remains controversial. We report the case of a 58 years old man with hypertension disease who was admitted in emergency department with suspicion of acute aortic dissection. Transoesophageal echocardiography showed IMH involving the descending aorta which spred afterwards to the ascending aorta. Patient was treated medically and echocardiographic follow-up showed that aortic hematoma remains stable. Two years later, patient is alive and the last TEE reveals disappearance of hematoma in ascending aorta and decrease of it in descending aorta.     

Aortic intramural hematoma: Current diagnostic and therapeutic recommendations

Opinion statement Aortic intramural hematoma (IMH) is an acute, potentially lethal disorder that is similar to but pathologically distinct from acute aortic dissection. Although hemorrhage into the aortic media occurs in both disorders, an intimal tear with resultant false lumen is not present in IMH. Instead, hemorrhage occurs within the aortic wall either due to rupture of the vasa vasorum or, less commonly, because of an atherosclerotic penetrating aortic ulcer. The most common risk factors associated with IMH are hypertension, atherosclerosis, and advanced age. IMH is life-threatening because the hematoma may extend along or rupture through the aorta, leading to hemothorax, cardiac tamponade, stroke, mesenteric ischemia, or renal insufficiency. Optimal treatment is still somewhat controversial; however, there is no question that hypertension must be treated effectively and immediately. This is usually best accomplished by intravenous infusion of β-blocking agents, with or without the addition of sodium nitroprusside. Recent studies support surgical treatment (ie, aortic root replacement) for IMH involving the ascending aorta, although some subsets of this population may be at lower risk and may benefit from medical therapy alone. In patients with IMH involving only the descending aorta, medical therapy alone is recommended (unless impending rupture, aortic aneurysm, or end-organ ischemia occurs). Patients who survive the acute event require intensive treatment of hypertension and frequent follow-up examinations. Because this population (especially the subset with penetrating aortic ulceration) is at high risk for aortic aneurysm and rupture, serial imaging studies of the aorta are essential.     

Case Report and Review of Literature: Late Retrograde Type A Aortic Dissection With Rupture after Repair of Type B Aortic Dissection with a GORE TAG Endovascular Prosthesis

Acute aortic dissection is the most common catastrophic condition of the aorta. Treatment options include open surgery and thoracic endovascular aortic reconstruction (TEVAR). We present a late Type A dissection as a complication of the management of descending aortic dissections with TEVAR and a review of the literature. TEVAR of the thoracic aorta is a viable treatment option for the management of complicated descending thoracic aortic dissections. Careful patient selection is necessary as medical therapy successfully treats the majority of uncomplicated Type B dissections. TEVAR should be reserved for patients with complicated Type B dissections or those who fail nonoperative management. Close postoperative monitoring is necessary when TEVAR is performed and should be accompanied by lifelong surveillance. A high level of suspicion is important to identify retrograde Type A dissections in these patients given its rarity and the ambiguity of its clinical presentation.     

Progression of an intramural hematoma to dissection

Intramural hematoma is a spontaneous, localized bleeding in the wall of the thoracic aorta without evidence of intimal tear. Clinically, intramural hematoma manifests itself as an acute thoracical pain in patients with hypertension and therefore shows parallels with the classical aortic dissection. In the literature there is controversial discussion whether intramural hematoma can be regarded as its own aortic pathology or a precursor in the development of classical aortic dissection. We present the case of a 66 year old male who showed an intramural hematoma of the descending aorta which rapidly progressed to classical dissection within 3 months. This finding was secondarily accompanied by a dilatation of the descending aorta which leads to operative treatment with replacement of the proximal aorta descendens. This case supports the hypothesis that intramural hematoma is a potential early manifestation of aortic dissection and at the same time stresses the necessity for frequent follow-up investigations and, if necessary, early operative therapy.     

Pathologic variants of thoracic aortic dissections. Penetrating atherosclerotic ulcers and intramural hematomas

This article confirms the existence of two variants of acute aortic pathology, the penetrating atherosclerotic ulcer (PAU) and the intramural hematoma (IMH), which are radiologically distinct from classic aortic dissection. Table 4 reviews the characteristics distinguishing PAU from classic aortic dissection and IMH. We took as a matter of definition that classic aortic dissection involves a flap which traverses the aortic lumen. We defined PAU and IMH as nonflap lesions, with PAU demonstrating a crater extending from the aortic lumen into the space surrounding the aortic lumen. This categorization can be summarized with the expression, "no flap, no dissection." With these definitions made, re-review of the imaging studies for the present report identified 36 such lesions out of 214 cases originally read as aortic dissection. Therefore, these variant lesions accounted for over 1 out of 8 acute aortic pathologies. Besides confirming the existence of the conditions, PAU and IMH, as distinct radiographic lesions, this series strongly suggests that these two conditions constitute distinct clinical entities as well. Table 4 summarizes the clinical patterns of these two entities as apparent from the present study, and contrasts them with classic aortic dissections. In particular, the following observations, some of which are consonant findings in smaller series, can be made regarding the typical patient profiles of PAU and IMH from the present study: The patients with PAU and IMH are distinctly older than those with type A aortic dissection (74.0 and 73.9 versus 56.5 years, P = 0.0001). Although not statistically significant, PAU and IMH patients tend to be older than patients with type B aortic dissections as well. For PAU and IMH, unlike aortic dissection, the concentration in the elderly is manifested in a very small standard deviation of the mean age (see Fig. 13); these two entities, PAU and IMH, are essentially diseases of the seventh, eighth, and ninth decades of life. Patients with PAU and IMH are almost invariably hypertensive (about 94% of cases). The pain of PAU and IMH mimics that of classic aortic dissection, with anterior symptoms in the ascending aortic lesions and intrascapular or back pain with descending aortic lesions. Unlike classic dissection, PAU and IMH do not produce branch vessel compromise or occlusion and do not result in ischemic manifestations in the extremities or visceral organs. PAU and IMH are more focal lesions than classic aortic dissection, which frequently propagates for much or the entire extent of the thoracoabdominal aorta. PAU is uniformly associated with severe aortic arteriosclerosis and calcification, whereas classic dissection often occurs in aortas with minimal arteriosclerosis and calcification. PAU and IMH tend to occur in even larger aortas than classic aortic dissection (6.2 and 5.5 versus 5.2 cm, P = 0.01). PAU and IMH are strongly associated with AAA, which is seen concomitantly in 42.1% of PAU patients and 29.4% of IMH patients. PAU and IMH are largely diseases of the descending aorta (90% for PAU and 71% for IMH). Although our pathology data is limited, we do feel that an inherent difference in the histologic intramural level of the hematoma may underlie the pathophysiologic process that determines which patient develops a typical dissection and which develops an intramural hematoma. In particular, we feel that the level of blood collection is more superficial, closer to the adventitia, in IMH than in typical aortic dissection. This may explain why the inner layer does not prolapse into the aorta on imaging studies or when the aorta is opened in the operating room. This more superficial location would also explain the high rupture rates as compared to classic aortic dissection (Fig. 14, Table 3). We did find PAU and IMH to behave much more malignantly than typical descending aortic dissection. As seen in Figure 6, the rupture rate is much higher than for aortic dissection. Docume     

“象鼻”支架术治疗Stanford B型主动脉夹层胸主动脉腔内修复术后Ⅰ型内漏

目的:回顾应用支架"象鼻"术治疗Stanford B型主动脉夹层胸主动脉腔内修复术(TEVAR)术后Ⅰ型内漏的临床效果。方法:2009年3月至2013年1月,首都医科大学附属北京安贞医院,收治的Stanford B型主动脉夹层TEVAR术后Ⅰ型内漏12例患者进行回顾性分析。12例患者均为男性,平均年龄(50.2±6.2)岁,平均身高(171.92±4.98)cm,平均体质量(77.50±8.43)kg,所有患者均无相关家族遗传病史,均有高血压病史,与第一次TEVAR术间隔时间平均34.4个月。支架"象鼻"术均在全麻体外循环下进行。如漏口暴露清楚,可缝闭漏口;如置入支架裸区妨碍象鼻支架缝合,可剪除部分裸露部分金属支架或将置入支架取出;如漏口累及左锁骨下动脉开口,可将左锁骨下动脉近端缝闭,截断左锁骨下动脉,其远端与左颈总动脉行端侧吻合,建立左颈总动脉至左锁骨下动脉转流或8mm人工血管行升主动脉至左腋动脉或左锁骨下动脉转流。于之前置入的支架内置入26~30mm Microport术中支架血管,覆盖内漏破口。术后随访6~48个月,平均6.53个月。结果:12例支架"象鼻"术均为择期手术,其中7例患者漏口位置累及左锁骨下动脉,4例剪除置入支架金属裸区;1例将置入支架取出;3例术中支架血管近端吻合于左锁骨下动脉以远,8例吻合于左颈总动脉与左锁骨下动脉之间;4例同期行左颈总动脉至左锁骨下动脉转流术;2例行升主动脉-左锁骨下动脉转流术;2例行升主动脉-左腋动脉转流术;1例患者因合并二尖瓣关闭不全同期行二尖瓣置换术;1例合并迷走右锁骨下动脉的患者同期行升主动脉-右腋动脉转流术。12例患者手术时间为平均(5.92±1.14)小时,平均住院时间为(21.92±9.14)天,2例患者术后出现围术期并发症,其中1例胸骨哆开,行再次胸骨固定痊愈;1例术前肾功能不全,术后出现急性肾衰竭,经透析治疗后肾功能恢复。本组患者均顺利出院。所有患者术后内漏均消失,术后随访6~48个月,平均6.53个月,均无复发。在术后随访期间,3例患者支架远端病变需再次处理,1例患者术后7个月出现支架感染、咯血、死亡。结论:应用支架"象鼻"术治疗Stanford B型主动脉夹层TEVAR术后Ⅰ型内漏,有较好的临床疗效,但远期效果仍需进一步观察。